The insulin dose was reduced by 20% at randomization for patients with baseline A1C 8% and fixed until liraglutide dose escalation was complete
While these shots arent a magic solution to melt away fat, they can definitely work as a booster
CagriSema (cagrilintide plus semaglutide) produced 20.4 percent mean weight loss at 68 weeks in the REDEFINE 1 trial, with 60 percent of participants losing at least 20 percent of body weight, approaching bariatric surgery outcomes
These represent areas of published scientific study in laboratory and animal settings not claims about outcomes in humans, and not therapeutic claims
Falvo DJ, Grimont A, Zumbo P, et al
The peptide also engages VEGFR2 (vascular endothelial growth factor receptor), promoting angiogenesis